“Efficacy and Safety of Roflumilast Cream 0.15% in Adults and Children Aged ≥6 Years With Mild to Moderate Atopic Dermatitis in Two Phase 3 Trials (INTEGUMENT-1 and INTEGUMENT-2)”. 2023. SKIN The Journal of Cutaneous Medicine 7 (4): s220. https://doi.org/10.25251/skin.7.supp.220.